Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M E, Luggen"'
Autor:
H J, Williams, G S, Alarcon, R, Joks, V D, Steen, K, Bulpitt, D O, Clegg, C M, Ziminski, M E, Luggen, E W, St Clair, R F, Willkens, C, Yarboro, J G, Morgan, M J, Egger, J R, Ward
Publikováno v:
The Journal of rheumatology. 26(4)
(1) To review the diagnoses after 10 years in patients who were identified within 12 months of the onset of well established and undifferentiated connective tissue diseases (CTD). (2) To examine the death rates and disease remissions in these patient
Autor:
H J, Williams, G S, Alarcón, R, Neuner, V D, Steen, K, Bulpitt, D O, Clegg, C M, Ziminski, M E, Luggen, R P, Polisson, R F, Willkens, C, Yarboro, J, Morgan, M J, Egger, J R, Ward
Publikováno v:
The Journal of rheumatology. 25(2)
To review the diagnoses after 5 years in patients who were identified within 12 months of the onset of well established and undifferentiated connective tissue diseases (CTD); to examine death rates and disease remissions in these patients.This incept
Autor:
M E, Luggen
Publikováno v:
Revue du rhumatisme (Ed. francaise : 1993). 61(10 Pt 2)
Many new nonsteroidal antiinflammatory agents are available for the treatment of rheumatoid arthritis. Although they all seem effective and reasonably safe, it is difficult to determine whether some are superior over others under real life conditions
Autor:
G S, Alarcón, G V, Williams, J Z, Singer, V D, Steen, D O, Clegg, H E, Paulus, L M, Billingsley, M E, Luggen, R P, Polisson, R F, Willkens
Publikováno v:
The Journal of rheumatology. 18(9)
We identified a cohort of 410 patients with connective tissue disorders (CTD) of less than or equal to 1 year duration among the participating clinics of the Cooperative Systematic Studies of the Rheumatic Diseases Program. Fifty-seven had rheumatic
Autor:
D O, Clegg, H J, Williams, J Z, Singer, V D, Steen, S, Schlegel, C, Ziminski, G S, Alarcón, M E, Luggen, R P, Polisson, R F, Willkens
Publikováno v:
The Journal of rheumatology. 18(9)
The presence of antinuclear antibodies (ANA) in the serum is a common finding in various connective tissue disorders, but usefulness of these antibodies in making diagnoses or prognoses is not known. We report the results of a panel of ANA determinat
Autor:
E V, Hess, M E, Luggen
Publikováno v:
The Journal of rheumatology. 16(9)
Publikováno v:
The Journal of rheumatology. 16(12)
To determine if any nonsteroidal antiinflammatory drug (NSAID) was superior in the treatment of rheumatoid arthritis, duration of use of each drug was employed as a measure of combined efficacy and tolerability. Duration was treated as survival data